Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2773 to 2784 of 2788 entries
Sorted by: Best Match Show Resources per page
Addressing Issues of Cancer Disparities, Equity, and Inclusion Through Systemized Quality Improvement.

JCO oncology practice

Kamal AH, Power S, Patierno SR.
PMID: 34181463
JCO Oncol Pract. 2021 Aug;17(8):461-462. doi: 10.1200/OP.21.00282. Epub 2021 Jun 28.

No abstract available.

Cite
Kamal AH, Power S, Patierno SR. Addressing Issues of Cancer Disparities, Equity, and Inclusion Through Systemized Quality Improvement. JCO Oncol Pract. 2021;17(8):461-462doi: 10.1200/OP.21.00282.
Kamal, A. H., Power, S., & Patierno, S. R. (2021). Addressing Issues of Cancer Disparities, Equity, and Inclusion Through Systemized Quality Improvement. JCO oncology practice, 17(8), 461-462. https://doi.org/10.1200/OP.21.00282
Kamal, Arif H, et al. "Addressing Issues of Cancer Disparities, Equity, and Inclusion Through Systemized Quality Improvement." JCO oncology practice vol. 17,8 (2021): 461-462. doi: https://doi.org/10.1200/OP.21.00282
Kamal AH, Power S, Patierno SR. Addressing Issues of Cancer Disparities, Equity, and Inclusion Through Systemized Quality Improvement. JCO Oncol Pract. 2021 Aug;17(8):461-462. doi: 10.1200/OP.21.00282. Epub 2021 Jun 28. PMID: 34181463.
Copy Download .nbib Format: NLM
[Psycho-oncology].

Der Nervenarzt

Haeck M, Franke S, Wiskemann J, Mathiak K.
PMID: 23069897
Nervenarzt. 2012 Nov;83(11):1468-76. doi: 10.1007/s00115-012-3669-4.

Psycho-oncology addresses the psychosocial care of patients with cancer. Systematic research on the interactions between biological, psychological and social factors before, during and after cancer has only been carried out for a few decades. All cancer patients, their relatives...

Cite
Haeck M, Franke S, Wiskemann J, et al. Psychoonkologie. [Psycho-oncology]. Nervenarzt. 2012;83(11):1468-76doi: 10.1007/s00115-012-3669-4.
Haeck, M., Franke, S., Wiskemann, J., & Mathiak, K. (2012). Psychoonkologie. [Psycho-oncology]. Der Nervenarzt, 83(11), 1468-76. https://doi.org/10.1007/s00115-012-3669-4
Haeck, M, et al. "Psychoonkologie." [Psycho-oncology]. Der Nervenarzt vol. 83,11 (2012): 1468-76. doi: https://doi.org/10.1007/s00115-012-3669-4
Haeck M, Franke S, Wiskemann J, Mathiak K. Psychoonkologie. [Psycho-oncology]. Nervenarzt. 2012 Nov;83(11):1468-76. doi: 10.1007/s00115-012-3669-4. German. PMID: 23069897.
Copy Download .nbib Format: NLM
I'm not putting on that floral gown: Enforcement and resistance of gender expectations for transgender people with cancer.

Patient education and counseling

Alpert AB, Gampa V, Lytle MC, Manzano C, Ruddick R, Poteat T, Quinn GP, Kamen CS.
PMID: 33745786
Patient Educ Couns. 2021 Oct;104(10):2552-2558. doi: 10.1016/j.pec.2021.03.007. Epub 2021 Mar 10.

OBJECTIVES: Understanding barriers to care for transgender people with cancer is necessary to increase oncologic care access. Little has been published regarding the experiences of transgender people with cancer. We sought to explore these experiences, assess barriers to oncologic...

Cite
Alpert AB, Gampa V, Lytle MC, et al. I'm not putting on that floral gown: Enforcement and resistance of gender expectations for transgender people with cancer. Patient Educ Couns. 2021;104(10):2552-2558doi: 10.1016/j.pec.2021.03.007.
Alpert, A. B., Gampa, V., Lytle, M. C., Manzano, C., Ruddick, R., Poteat, T., Quinn, G. P., & Kamen, C. S. (2021). I'm not putting on that floral gown: Enforcement and resistance of gender expectations for transgender people with cancer. Patient education and counseling, 104(10), 2552-2558. https://doi.org/10.1016/j.pec.2021.03.007
Alpert, Ash B, et al. "I'm not putting on that floral gown: Enforcement and resistance of gender expectations for transgender people with cancer." Patient education and counseling vol. 104,10 (2021): 2552-2558. doi: https://doi.org/10.1016/j.pec.2021.03.007
Alpert AB, Gampa V, Lytle MC, Manzano C, Ruddick R, Poteat T, Quinn GP, Kamen CS. I'm not putting on that floral gown: Enforcement and resistance of gender expectations for transgender people with cancer. Patient Educ Couns. 2021 Oct;104(10):2552-2558. doi: 10.1016/j.pec.2021.03.007. Epub 2021 Mar 10. PMID: 33745786.
Copy Download .nbib Format: NLM
Patient-provider communication during second opinion consultations in oncology.

Patient education and counseling

Lehmann V, Smets EMA, de Jong M, de Vos FYF, Stouthard JM, Hillen MA.
PMID: 33744055
Patient Educ Couns. 2021 Oct;104(10):2490-2497. doi: 10.1016/j.pec.2021.03.011. Epub 2021 Mar 09.

OBJECTIVE: Providing a second opinion (SO) in oncology is complex, and communication during SOs remains poorly understood. This study aimed to systematically observe how patients and oncologists communicate about SO-specific topics (i.e., patient motivation, the referring oncologist, treatment transfer/back-referral),...

Cite
Lehmann V, Smets EMA, de Jong M, et al. Patient-provider communication during second opinion consultations in oncology. Patient Educ Couns. 2021;104(10):2490-2497doi: 10.1016/j.pec.2021.03.011.
Lehmann, V., Smets, E. M. A., de Jong, M., de Vos, F. Y. F., Stouthard, J. M., & Hillen, M. A. (2021). Patient-provider communication during second opinion consultations in oncology. Patient education and counseling, 104(10), 2490-2497. https://doi.org/10.1016/j.pec.2021.03.011
Lehmann, Vicky, et al. "Patient-provider communication during second opinion consultations in oncology." Patient education and counseling vol. 104,10 (2021): 2490-2497. doi: https://doi.org/10.1016/j.pec.2021.03.011
Lehmann V, Smets EMA, de Jong M, de Vos FYF, Stouthard JM, Hillen MA. Patient-provider communication during second opinion consultations in oncology. Patient Educ Couns. 2021 Oct;104(10):2490-2497. doi: 10.1016/j.pec.2021.03.011. Epub 2021 Mar 09. PMID: 33744055.
Copy Download .nbib Format: NLM
An NIR-Fluorophore-Based Theranostic for Selective Initiation of Tumor Pyroptosis-Induced Immunotherapy.

Small (Weinheim an der Bergstrasse, Germany)

Wang K, Xiao X, Jiang M, Li J, Zhou J, Yuan Y.
PMID: 34323375
Small. 2021 Sep;17(36):e2102610. doi: 10.1002/smll.202102610. Epub 2021 Jul 29.

Pyroptosis is an inflammatory form of programmed cell death that can effectively eliminate malignant cells and boost anticancer immunity. However, most of the current pyroptosis inducers lack cell selectivity, which may cause severe side effects for cancer therapy. In...

Cite
Wang K, Xiao X, Jiang M, et al. An NIR-Fluorophore-Based Theranostic for Selective Initiation of Tumor Pyroptosis-Induced Immunotherapy. Small. 2021;17(36):e2102610doi: 10.1002/smll.202102610.
Wang, K., Xiao, X., Jiang, M., Li, J., Zhou, J., & Yuan, Y. (2021). An NIR-Fluorophore-Based Theranostic for Selective Initiation of Tumor Pyroptosis-Induced Immunotherapy. Small (Weinheim an der Bergstrasse, Germany), 17(36), e2102610. https://doi.org/10.1002/smll.202102610
Wang, Kewei, et al. "An NIR-Fluorophore-Based Theranostic for Selective Initiation of Tumor Pyroptosis-Induced Immunotherapy." Small (Weinheim an der Bergstrasse, Germany) vol. 17,36 (2021): e2102610. doi: https://doi.org/10.1002/smll.202102610
Wang K, Xiao X, Jiang M, Li J, Zhou J, Yuan Y. An NIR-Fluorophore-Based Theranostic for Selective Initiation of Tumor Pyroptosis-Induced Immunotherapy. Small. 2021 Sep;17(36):e2102610. doi: 10.1002/smll.202102610. Epub 2021 Jul 29. PMID: 34323375.
Copy Download .nbib Format: NLM
Multidisciplinary treatment of cancer.

Updates in surgery

Tebala GD, Bond-Smith G.
PMID: 32415665
Updates Surg. 2021 Feb;73(1):349-350. doi: 10.1007/s13304-020-00794-7. Epub 2020 May 15.

No abstract available.

Cite
Tebala GD, Bond-Smith G. Multidisciplinary treatment of cancer. Updates Surg. 2020;73(1):349-350doi: 10.1007/s13304-020-00794-7.
Tebala, G. D., & Bond-Smith, G. (2021). Multidisciplinary treatment of cancer. Updates in surgery, 73(1), 349-350. https://doi.org/10.1007/s13304-020-00794-7
Tebala, Giovanni D, and Bond-Smith, Giles. "Multidisciplinary treatment of cancer." Updates in surgery vol. 73,1 (2021): 349-350. doi: https://doi.org/10.1007/s13304-020-00794-7
Tebala GD, Bond-Smith G. Multidisciplinary treatment of cancer. Updates Surg. 2021 Feb;73(1):349-350. doi: 10.1007/s13304-020-00794-7. Epub 2020 May 15. PMID: 32415665.
Copy Download .nbib Format: NLM
The missing voice in multidisciplinary tumor boards.

Journal of geriatric oncology

Rocque G, Wheeler S, Williams GR.
PMID: 33722503
J Geriatr Oncol. 2021 Nov;12(8):1157-1158. doi: 10.1016/j.jgo.2021.03.004. Epub 2021 Mar 12.

No abstract available.

Cite
Rocque G, Wheeler S, Williams GR. The missing voice in multidisciplinary tumor boards. J Geriatr Oncol. 2021;12(8):1157-1158doi: 10.1016/j.jgo.2021.03.004.
Rocque, G., Wheeler, S., & Williams, G. R. (2021). The missing voice in multidisciplinary tumor boards. Journal of geriatric oncology, 12(8), 1157-1158. https://doi.org/10.1016/j.jgo.2021.03.004
Rocque, Gabrielle, et al. "The missing voice in multidisciplinary tumor boards." Journal of geriatric oncology vol. 12,8 (2021): 1157-1158. doi: https://doi.org/10.1016/j.jgo.2021.03.004
Rocque G, Wheeler S, Williams GR. The missing voice in multidisciplinary tumor boards. J Geriatr Oncol. 2021 Nov;12(8):1157-1158. doi: 10.1016/j.jgo.2021.03.004. Epub 2021 Mar 12. PMID: 33722503; PMCID: PMC8435048.
Copy Download .nbib Format: NLM
COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic.

British journal of cancer

Lee AJX, Purshouse K.
PMID: 33767417
Br J Cancer. 2021 May;124(11):1777-1784. doi: 10.1038/s41416-021-01324-x. Epub 2021 Mar 25.

The SARS-Cov-2 pandemic in 2020 has caused oncology teams around the world to adapt their practice in the aim of protecting patients. Early evidence from China indicated that patients with cancer, and particularly those who had recently received chemotherapy...

Cite
Lee AJX, Purshouse K. COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic. Br J Cancer. 2021;124(11):1777-1784doi: 10.1038/s41416-021-01324-x.
Lee, A. J. X., & Purshouse, K. (2021). COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic. British journal of cancer, 124(11), 1777-1784. https://doi.org/10.1038/s41416-021-01324-x
Lee, Alvin J X, and Purshouse, Karin. "COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic." British journal of cancer vol. 124,11 (2021): 1777-1784. doi: https://doi.org/10.1038/s41416-021-01324-x
Lee AJX, Purshouse K. COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic. Br J Cancer. 2021 May;124(11):1777-1784. doi: 10.1038/s41416-021-01324-x. Epub 2021 Mar 25. PMID: 33767417; PMCID: PMC7992513.
Copy Download .nbib Format: NLM
Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course.

The oncologist

Vogt J, Beyer F, Sistermanns J, Kuon J, Kahl C, Alt-Epping B, Stevens S, Ahlborn M, George C, Heider A, Tienken M, Loquai C, Stahlhut K, Ruellan A, Kubin T, Dietz A, Oechsle K, Mehnert-Theuerkauf A, van Oorschot B, Thomas M, Ortmann O, Engel C, Lordick F.
PMID: 33687742
Oncologist. 2021 Jun;26(6):e1058-e1065. doi: 10.1002/onco.13751. Epub 2021 Mar 30.

BACKGROUND: Although current guidelines advocate early integration of palliative care, symptom burden and palliative care needs of patients at diagnosis of incurable cancer and along the disease trajectory are understudied.MATERIAL AND METHODS: We assessed distress, symptom burden, quality of...

Cite
Vogt J, Beyer F, Sistermanns J, et al. Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course. Oncologist. 2021;26(6):e1058-e1065doi: 10.1002/onco.13751.
Vogt, J., Beyer, F., Sistermanns, J., Kuon, J., Kahl, C., Alt-Epping, B., Stevens, S., Ahlborn, M., George, C., Heider, A., Tienken, M., Loquai, C., Stahlhut, K., Ruellan, A., Kubin, T., Dietz, A., Oechsle, K., Mehnert-Theuerkauf, A., van Oorschot, B., Thomas, M., Ortmann, O., Engel, C., Lordick, F. (2021). Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course. The oncologist, 26(6), e1058-e1065. https://doi.org/10.1002/onco.13751
Vogt, Jeannette, et al. "Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course." The oncologist vol. 26,6 (2021): e1058-e1065. doi: https://doi.org/10.1002/onco.13751
Vogt J, Beyer F, Sistermanns J, Kuon J, Kahl C, Alt-Epping B, Stevens S, Ahlborn M, George C, Heider A, Tienken M, Loquai C, Stahlhut K, Ruellan A, Kubin T, Dietz A, Oechsle K, Mehnert-Theuerkauf A, van Oorschot B, Thomas M, Ortmann O, Engel C, Lordick F. Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course. Oncologist. 2021 Jun;26(6):e1058-e1065. doi: 10.1002/onco.13751. Epub 2021 Mar 30. PMID: 33687742; PMCID: PMC8176980.
Copy Download .nbib Format: NLM
Emerging micro- and nanotechnologies in cancer diagnosis and therapy.

Biomedical microdevices

Zhang JXJ, Khademhosseini A.
PMID: 23813078
Biomed Microdevices. 2013 Aug;15(4):579-581. doi: 10.1007/s10544-013-9785-5.

No abstract available.

Cite
Zhang JXJ, Khademhosseini A. Emerging micro- and nanotechnologies in cancer diagnosis and therapy. Biomed Microdevices. 2013;15(4):579-581doi: 10.1007/s10544-013-9785-5.
Zhang, J. X. J., & Khademhosseini, A. (2013). Emerging micro- and nanotechnologies in cancer diagnosis and therapy. Biomedical microdevices, 15(4), 579-581. https://doi.org/10.1007/s10544-013-9785-5
Zhang, John X J, and Khademhosseini, Ali. "Emerging micro- and nanotechnologies in cancer diagnosis and therapy." Biomedical microdevices vol. 15,4 (2013): 579-581. doi: https://doi.org/10.1007/s10544-013-9785-5
Zhang JXJ, Khademhosseini A. Emerging micro- and nanotechnologies in cancer diagnosis and therapy. Biomed Microdevices. 2013 Aug;15(4):579-581. doi: 10.1007/s10544-013-9785-5. PMID: 23813078.
Copy Download .nbib Format: NLM
Impact of the COVID-19 Pandemic on Cancer Clinical Trials.

Annals of surgical oncology

Boughey JC, Snyder RA, Kantor O, Zheng L, Chawla A, Nguyen TT, Hillman SL, Hahn OM, Mandrekar SJ, Roland CL.
PMID: 34236550
Ann Surg Oncol. 2021 Nov;28(12):7311-7316. doi: 10.1245/s10434-021-10406-2. Epub 2021 Jul 08.

The COVID-19 pandemic has had widespread impact on healthcare, resulting in modifications to how we perform cancer research, including clinical trials for cancer. The impact of some healthcare workers and study coordinators working remotely and patients minimizing visits to...

Cite
Boughey JC, Snyder RA, Kantor O, et al. Impact of the COVID-19 Pandemic on Cancer Clinical Trials. Ann Surg Oncol. 2021;28(12):7311-7316doi: 10.1245/s10434-021-10406-2.
Boughey, J. C., Snyder, R. A., Kantor, O., Zheng, L., Chawla, A., Nguyen, T. T., Hillman, S. L., Hahn, O. M., Mandrekar, S. J., & Roland, C. L. (2021). Impact of the COVID-19 Pandemic on Cancer Clinical Trials. Annals of surgical oncology, 28(12), 7311-7316. https://doi.org/10.1245/s10434-021-10406-2
Boughey, Judy C, et al. "Impact of the COVID-19 Pandemic on Cancer Clinical Trials." Annals of surgical oncology vol. 28,12 (2021): 7311-7316. doi: https://doi.org/10.1245/s10434-021-10406-2
Boughey JC, Snyder RA, Kantor O, Zheng L, Chawla A, Nguyen TT, Hillman SL, Hahn OM, Mandrekar SJ, Roland CL. Impact of the COVID-19 Pandemic on Cancer Clinical Trials. Ann Surg Oncol. 2021 Nov;28(12):7311-7316. doi: 10.1245/s10434-021-10406-2. Epub 2021 Jul 08. PMID: 34236550; PMCID: PMC8265286.
Copy Download .nbib Format: NLM
An overview and evaluation of the oncology family caregiver project: improving quality of life and quality of care for oncology family caregivers.

Psycho-oncology

Ferrell B, Hanson J, Grant M.
PMID: 23065694
Psychooncology. 2013 Jul;22(7):1645-52. doi: 10.1002/pon.3198. Epub 2012 Oct 14.

OBJECTIVE: With changes in health care, oncology family caregivers (FCs) provide the vast majority of patient care. Yet, FCs assume their role with little or no training and with limited resources within the cancer setting to support them. The...

Cite
Ferrell B, Hanson J, Grant M. An overview and evaluation of the oncology family caregiver project: improving quality of life and quality of care for oncology family caregivers. Psychooncology. 2012;22(7):1645-52doi: 10.1002/pon.3198.
Ferrell, B., Hanson, J., & Grant, M. (2013). An overview and evaluation of the oncology family caregiver project: improving quality of life and quality of care for oncology family caregivers. Psycho-oncology, 22(7), 1645-52. https://doi.org/10.1002/pon.3198
Ferrell, Betty, et al. "An overview and evaluation of the oncology family caregiver project: improving quality of life and quality of care for oncology family caregivers." Psycho-oncology vol. 22,7 (2013): 1645-52. doi: https://doi.org/10.1002/pon.3198
Ferrell B, Hanson J, Grant M. An overview and evaluation of the oncology family caregiver project: improving quality of life and quality of care for oncology family caregivers. Psychooncology. 2013 Jul;22(7):1645-52. doi: 10.1002/pon.3198. Epub 2012 Oct 14. PMID: 23065694; PMCID: PMC3821732.
Copy Download .nbib Format: NLM
Showing 2773 to 2784 of 2788 entries